|
EIF2S1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.102000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.366400E-04 |
| Normal-vs-Stage2 |
1.572230E-02 |
| Normal-vs-Stage3 |
8.874800E-01 |
| Normal-vs-Stage4 |
4.613400E-01 |
| Stage1-vs-Stage2 |
7.956000E-01 |
| Stage1-vs-Stage3 |
4.926000E-02 |
| Stage1-vs-Stage4 |
4.979800E-01 |
| Stage2-vs-Stage3 |
1.149400E-01 |
| Stage2-vs-Stage4 |
4.101400E-01 |
| Stage3-vs-Stage4 |
6.111000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.035900E-03 |
| Normal-vs-AfricanAmerican |
5.418000E-03 |
| Normal-vs-Asian |
6.098600E-01 |
| Caucasian-vs-AfricanAmerican |
7.840800E-01 |
| Caucasian-vs-Asian |
9.374200E-01 |
| AfricanAmerican-vs-Asian |
9.076800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.23370000000234E-05 |
| Normal-vs-Female |
5.902400E-01 |
| Male-vs-Female |
1.521780E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.697800E-03 |
| Normal-vs-Extreme_Weight |
2.555700E-04 |
| Normal-vs-Obese |
2.643600E-01 |
| Normal-vs-Extreme_Obese |
1.443050E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.091200E-01 |
| Normal_Weight-vs-Obese |
2.165600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.478200E-01 |
| Extreme_Weight-vs-Obese |
8.692300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.952400E-01 |
| Obese-vs-Extreme_Obese |
3.732600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.965200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.510500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.189640E-04 |
| Normal-vs-Age(81-100Yrs) |
1.898500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.439400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.345630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.898000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.537380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.921400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.466400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.12979999999874E-05 |
| Normal-VS-Type2 PRCC |
2.652200E-02 |
| Normal-VS-KIRP CIMP |
2.404000E-01 |
| Normal-VS-Unclassified PRCC |
5.078100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.501600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.027800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.833600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.085990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.784800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.614400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.784070E-04 |
| Normal-vs-N1 |
2.967800E-01 |
| Normal-vs-N2 |
4.13270000000354E-05 |
| N0-vs-N1 |
9.061400E-03 |
| N0-vs-N2 |
1.408580E-01 |
| N1-vs-N2 |
5.161800E-02 |
|
|
